NCT06074393

Brief Summary

The goal of this study is to understand how support groups can help people who care for individuals with Parkinson's Disease and Related Disorders (PDRD). The investigators want to find answers to these questions:

  • How do these support groups make caregivers feel?
  • Do these support groups help caregivers cope better and improve their quality of life? Participants in this study will join support groups where they can talk to other caregivers and learn from experts. These groups will meet every two weeks for four months, and there will be sessions on different topics like self-care, coping skills, and mindfulness. Caregivers will share their experiences and ask questions in these sessions. Information will be collected before and after the support group meetings using surveys. These surveys will help understand how the support groups affect caregivers. Things like caregiver burden, coping strategies, and overall well-being will be measured. The main goal is to reduce the burden on caregivers of people with PDRD and improve their quality of life. It is believed that these support groups can make a positive difference, and this study will help understand how they work.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

October 19, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2024

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

October 12, 2023

Status Verified

October 1, 2023

Enrollment Period

1 year

First QC Date

September 28, 2023

Last Update Submit

October 10, 2023

Conditions

Keywords

Support groupCare partners

Outcome Measures

Primary Outcomes (3)

  • Changes in Care Partner Burden: Assessed using ZBI-12.

    ZBI-12 is validated as a screening tool for advanced illness. The ZBI-12 is rated on a 12 items scale, with the severity of burden using a range of responses from 0 to 4 points per item and a total score range of 0 to 48. Scoring 0-10 is considered as a no to mild burden; 10-20, a mild to moderate burden and \>20, a high burden. It measures changes in physical, emotional, social, and financial problems that can be experienced by family caregivers.

    Enrollment and at the end of the Support Group. 1 and 16 weeks.

  • Changes in Coping Strategies: Evaluated with Brief-COPE scale.

    The Brief COPE (Coping Orientation to Problems Experienced) scale, composed of 28 items, each rated on a 4-point scale where 3 represents the highest score, exhibits a minimum value of 0 and a maximum value of 84. When interpreting Brief COPE scores, higher values are indicative of a potentially enhanced capacity to navigate stress and handle challenging situations. These elevated scores reflect a greater propensity to employ diverse coping strategies when confronted with difficulties.

    Enrollment and at the end of the Support Group. 1 and 16 weeks.

  • Changes in Quality of Life: Scrutinized using AC-QoL scale.

    The Adult Carer Quality of Life (AC-QoL) Scale encompasses both an overall scale and eight subscales. The overall scale yields scores ranging from 0 to 120, with higher scores signifying an enhanced quality of life for caregivers. Additionally, each of the eight subscales offers scores within a potential range of 0 to 15. Higher scores on these subscales indicate an improved quality of life for caregivers in specific domains pertaining to their caregiving responsibilities. This structured assessment provides valuable insights into the well-being of caregivers across multiple dimensions of their lives.

    Enrollment and at the end of the Support Group. 1 and 16 weeks.

Secondary Outcomes (1)

  • Satisfaction with Participation: Caregiver Support Group Satisfaction Survey

    Byweekly for 16 weeks

Study Arms (1)

Care partners of patients with advanced Parkinsonian Syndromes

EXPERIMENTAL

Care partners of patients with advanced Parkinsonian Syndromes will participate in a tailored support group

Behavioral: Tailored Support Group

Interventions

Participants engage in a secure, confidential environment, sharing caregiving insights and knowledge. Expert-led sessions, lasting 90 minutes, occur biweekly for 16 weeks, held via Zoom and at the University of Calgary's Cumming School of Medicine. These sessions take place twice annually, emphasizing the structured nature of the support group. Weekly themes include self-care, adaptation, coping skills, emotions, anticipatory grief, forgiveness, mindfulness, boundaries, and closure. Care partners actively participate by sharing experiences and asking questions in each session.

Also known as: Support Group
Care partners of patients with advanced Parkinsonian Syndromes

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Care partners of individuals with a confirmed diagnosis of Parkinsonian Syndrome.
  • Participants in the Calgary Movement Disorders Advanced Care pilot program (REB22-0545)

You may not qualify if:

  • Care partners with significant cognitive impairments that hinder participation with MoCA\<10 points.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Science Centre, University of Calgary

Calgary, Alberta, T2N 4N1, Canada

Location

MeSH Terms

Conditions

Parkinson DiseaseParkinsonian Disorders

Interventions

Self-Help Groups

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Veronica Bruno, MD, MPH

    University of Calgary

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Veronica Bruno, MD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The clinical trial is a prospective study analysing the effect of a tailored support group on care partner burden, coping strategies, and quality of life in care partners of patients with advanced Parkinsonian syndromes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor. Department of Clinical Neurosciences

Study Record Dates

First Submitted

September 28, 2023

First Posted

October 10, 2023

Study Start

October 19, 2023

Primary Completion

October 19, 2024

Study Completion

October 31, 2024

Last Updated

October 12, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations